Provided by Tiger Trade Technology Pte. Ltd.

CKLIFE SCIENCES

0.670
-0.040-5.63%
Volume:11.78M
Turnover:7.94M
Market Cap:6.44B
PE:-34.54
High:0.700
Open:0.700
Low:0.660
Close:0.710
52wk High:1.100
52wk Low:0.450
Shares:9.61B
HK Float Shares:9.61B
Volume Ratio:1.70
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.019
ROE:-5.12%
ROA:-0.72%
PB:1.70
PE(LYR):-34.54
PS:1.19

Loading ...

CK Life Sciences Plummets Over 4% Amid Widened Annual Loss and Surging R&D Costs

Stock News
·
Mar 20

BRIEF-CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln

Reuters
·
Mar 17

Revised title

Stock News
·
Mar 17

CK Life Sciences (00775.HK) Annual Loss Widens to HK$186.80 Million in 2025; Revenue Down 2% amid Higher R&D and Vineyard Writedowns

Bulletin Express
·
Mar 17

CK Life Sciences FY2025 loss attributable to shareholders widens 48% to HKD 186.81 million

Reuters
·
Mar 17

CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development

THOMSON REUTERS
·
Mar 10

BRIEF-CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development

Reuters
·
Mar 10

CK Life Sciences Forms New Unit to Advance Cancer Vaccine Research

MT Newswires Live
·
Mar 10

CK Life Sciences (00775) Forms Sequencio Therapeutics to Accelerate Cancer Vaccine Pipeline

Bulletin Express
·
Mar 10

CKLIFE SCIENCES Establishes Sequencio Therapeutics to Advance Cancer Vaccine Portfolio

Stock News
·
Mar 10

CKLIFE SCIENCES (Stock Code: 00775) Schedules Board Meeting to Approve Annual Results

Bulletin Express
·
Mar 05

CK Life Sciences sets board meeting to approve annual results release and consider final dividend

Reuters
·
Mar 05

CK Life Sciences (00775) Issues Monthly Return for February 2026

Bulletin Express
·
Mar 03

CKLIFE SCIENCES Shares Surge Over 4% Following Establishment of Scientific Advisory Board

Stock News
·
Feb 25

CK Life Sciences (00775) Releases January 2026 Monthly Return, Confirms Authorized Capital and Public Float

Bulletin Express
·
Feb 03

Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2B Development

THOMSON REUTERS
·
Jan 12

Zhitoong Stock Connect Shareholding Ratio Changes Statistics | December 26

Stock News
·
Dec 26, 2025

CKLIFE SCIENCES (00775): Halneuron® Phase 2b Study Interim Analysis Shows Positive Results in Chemotherapy-Induced Neuropathic Pain

Stock News
·
Dec 23, 2025

CK Life Sciences Subsidiary Dogwood Therapeutics Reports Positive Interim Results in Pain Drug Trial

Reuters
·
Dec 23, 2025

CK Life Sciences Int'l. (Holdings) Inc. (00775) Releases November 2025 Monthly Return, No Change in Share Capital

Bulletin Express
·
Dec 02, 2025